CXXC5 and metabolic dysfunction-associated steatohepatitis: The critical role of CXXC5 as a mediator of the pathogenesis of NASH was further confirmed by the absence of CXXC5 induction and any apparent pathological phenotypes by administration of KY19334 when the mice were fed a NCD (Supplementary Fig. 6a–i).